Free Trial
TSE:MDNA

Medicenna Therapeutics (MDNA) Stock Price, News & Analysis

Medicenna Therapeutics logo
C$0.99 -0.02 (-1.98%)
As of 10/3/2025 03:57 PM Eastern

About Medicenna Therapeutics Stock (TSE:MDNA)

Advanced

Key Stats

Today's Range
C$0.97
C$1.02
50-Day Range
C$0.81
C$1.19
52-Week Range
C$0.78
C$2.62
Volume
45,035 shs
Average Volume
43,376 shs
Market Capitalization
C$82.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MDNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicenna Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MDNA Stock News Headlines

Buffett, Gates and Bezos Dumping Stocks
The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It’s something we haven’t see in America for more than a century.tc pixel
Medicenna Therapeutics reports clinical data from ABILITY-1 study of MDNA11
See More Headlines

MDNA Stock Analysis - Frequently Asked Questions

Medicenna Therapeutics' stock was trading at C$1.65 at the start of the year. Since then, MDNA stock has decreased by 40.0% and is now trading at C$0.99.

Shares of MDNA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicenna Therapeutics investors own include Manulife Financial (MFC), Gilead Sciences (GILD), OPKO Health (OPK), Air Canada (AC), Athersys (ATHX), Birchcliff Energy (BIR) and Canadian Natural Resources (CNQ).

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:MDNA
CIK
N/A
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$25.98 million
Net Margins
-533,640.00%
Pretax Margin
N/A
Return on Equity
-159.88%
Return on Assets
-32.80%

Debt

Debt-to-Equity Ratio
0.88
Current Ratio
11.40
Quick Ratio
4.65

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.86 per share
Price / Cash Flow
1.15
Book Value
C$0.26 per share
Price / Book
3.79

Miscellaneous

Outstanding Shares
83,410,000
Free Float
N/A
Market Cap
C$82.58 million
Optionable
Not Optionable
Beta
2.80
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (TSE:MDNA) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners